- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04149873
Effectness of Treatment With Mechanical Insufflation-Exsufflation
Effectness of Treatment With Mechanical Insufflation-Exsufflation in Surgical Critically Ill Patients With Impaired Cough Function
Study Overview
Detailed Description
Endotracheal intubation and mechanical ventilation are always used to treat acute respiratory failure in critically ill patients. Successful weaning from ventilator and extubation are crucial to determine the prognosis when patient's underlying disease getting improvement. The reasons for extubation failure include lack of improvement of on the work of breathing, hypoxemia, respiratory acidosis, conscious disturbance and retained respiratory secretions, etc. In our clinical practice, the factor of retained respiratory secretions plays an important role in successful extubation.
Traditional chest physiotherapy (CPT) is commonly used to help the critically patients in the effective expulsion of airway secretions. In recent years, new advanced techniques mechanical insufflations-exsufflation (MI-E) and high frequency chest wall oscillation (HFCWO)have been developed to get more effective to remove secretions for patients suffered from acute respiratory failure. The above devices have been described as an effective techniques for patients with chronic neuromuscular weakness, cystic fibrosis and bronchiectasis. By the knowledge, only one study mentioned about MI-E could reduce the reintubation rate and shorten the ICU length of stay. But its limitations include less of case number and not focusing on impaired cough function patients.
In this study, patients defined with impaired cough function as maximum expiratory pressure (MEP) < 60cmH2O. Collected the patients in our surgical ICU who are able to reach 6-8CC/IBW under pressure support mode for 24 hours and MEP < 60cmH2O. Then the patients will be allocated to 3 groups to receive (1) conventional CPT (control group) (2) MI-E (study group A) (3) MI-E plus CPT (study group B) until 48 hours after extubation. Reintubation rates, ICU mortality and post-extubation ICU length of stay will be analyzed to evaluate its effects.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Tainan, Taiwan, 710
- Department of Intensive Care Medicine; Chi Mei Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria.
- 1.Written Informed Consent given by the patient or, if not possible, by a legally authorized representative and/or an independent physician as authorized by the competent ethics committee (EC) or independent review board (IRB) and local regulations.
- 2.To be at least 20 years of age.
- 3.To be treated in an ICU at the time of enrollment.
- 4.Endotracheal tube in place
5.The patient is mechanically ventilated and reach:
- Ventialtopr: Pressure support mode
- reach 6-8CC/IBW, ideal body weight for 24 hours
- MEP, maximum expiratory pressure < 60cmH2O
Exclusion Criteria
- 1.The patient or legally authorized representative refuse
- 2.< 20 years of age.
- 3.Neither endotracheal tube nor mechanical ventilator use
4.The patient is mechanically ventilated, but:
- The ventialtopr mode NOT: Pressure support mode
- No reach 6-8CC/IBW, ideal body weight for 24 hours
- MEP, maximum expiratory pressure > 60cmH2O
- 5.Participation as subject in another interventional study within 30 days prior to the first dose of study treatment, or planned participation in such a study during the study or within 30 days of its completion by the patient.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Control group
Control group' has the treatment with [Physical chest care ]
|
MIE
|
Placebo Comparator: Experimental group-A
'Experimental group-A' has the treatment with [Mechanical-Insufflation- Exsufflation]
|
MIE
|
Experimental: Experimental group-B
'Experimental group-B' has the treatment with [Mechanical-Insufflation- Exsufflation] and [Physical chest care]
|
MIE
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
mortality rate
Time Frame: 1 year
|
One year mortality rate
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Kuo-Chen Cheng, Chief, Chi Mei Medical Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CMFHR 10460(IRB10407-008)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mortality
-
Duke-NUS Graduate Medical SchoolActive, not recruiting
-
Chimei Medical CenterCompleted
-
Queens College, The City University of New YorkNational Cancer Institute (NCI)UnknownMortality
-
Duke UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsTerminated
-
University Hospital, Clermont-FerrandAustralian Catholic University; WittyFitUnknown
-
FHI 360Ministère de la Santé et de l´Hygiène Publique (Côte d'Ivoire)Recruiting
-
University of California, San FranciscoBill and Melinda Gates Foundation; Centre de Recherche en Sante de Nouna, Burkina...CompletedChildhood MortalityBurkina Faso
-
Public Health Foundation of IndiaUBS Optimus Foundation; The Children's Investment Fund FoundationCompleted
-
Hospital Vila Franca de XiraUnknownHospital MortalityPortugal
Clinical Trials on MIE
-
The Second Hospital of Shandong UniversityRecruitingEsophageal CancerChina
-
Vall d'Hebron Institute ResearchGermans Trias i Pujol Hospital; Hospital Vall d'Hebron; Hospital Universitario...RecruitingLung Transplant FailureSpain
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group BCompleted
-
Xiangbei Welman Pharmaceutical Co., LtdUnknownRespiratory Tract Infections | Urinary Tract Infections
-
Odense University HospitalCompleted
-
Cancer Institute and Hospital, Chinese Academy...Peking University Third Hospital; Hunan Cancer Hospital; Peking University Cancer... and other collaboratorsUnknownEsophageal CarcinomaChina
-
Fudan UniversityShanxi Province Cancer Hospital; The First Hospital of Jilin University; Fujian... and other collaboratorsUnknownEsophageal CancerChina
-
Chengchu ZhuSun Yat-sen University; Fudan UniversityUnknownSquamous Cell Esophageal CarcinomaChina
-
Xiangbei Welman Pharmaceutical Co., LtdCompletedRespiratory Tract Infections | Urinary Tract InfectionsChina
-
Shanghai Zhongshan HospitalRuijin Hospital; Tianjin Medical University Cancer Institute and Hospital; Shanghai... and other collaboratorsCompletedEsophageal Squamous Cell Carcinoma Stage cT3-4aN0-1M0China